Avadel Pharmaceuticals (AVDL) PT Raised to $6 at Laidlaw
Tweet Send to a Friend
Laidlaw analyst Francois Brisebois raised the price target on Avadel Pharmaceuticals (NASDAQ: AVDL) to $6.00 (from $3.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
